Clinical trial
Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
NCT07263035 is registered in ClinicalTrials.gov with Lakeland Regional Health Systems, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
- Lead sponsor
- Lakeland Regional Health Systems, Inc.
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- April 1, 2026
- Completion date
- September 1, 2027
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute heart failure (ahf), heart failure, heart failure - nyha ii - iv, heart failure acute